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Background: The accuracy and precision of the Friedewald formula for estimating low-density lipoprotein cholesterol
(LDL-C) is questionable. Although other formulae have been developed, only a few studies compare them. Thus, we
compared the efficiencies of various formulae, based on the age and gender of adults, to determine which ones yield
more accurate estimations in terms of mean squared error, and which formulae underestimated and overestimated
LDL-C performance.
Methods: This study compares various formulae in terms of mean squared error (MSE), as well as underestimation and
overestimation of LDL-C concentrations, using subjects of various ages and both genders. Six groups were examined in
this study based on age and gender: males 20–44 years old, 45–64, and 65 and above, and females in the same three
age ranges.
Results: The results show that the Friedewald formula has relatively low accuracy, and while its performance among
older (aged 45 and above) women with triglyceride concentrations≤ 400 mg/dL is better than that with other groups,
it is still more inaccurate than the other formulae. In terms of prediction errors and mean squared errors, Tsai’s formula
(TF) and a calibrated TF provide the most accurate results with regard to the LDL-C concentration. Moreover, based on
a cross-validation of age and gender, these two formulae provide highly accurate results for the LDL-C concentrations
of all the studied groups, except for women aged 20–44 years.
Conclusions: Based on the experimental results, this study provides a set of benchmarks for the formulae used in
LDL-C tests when considering the factors of age and gender. Therefore, it is a valuable method for providing formula
benchmarking.
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Medical research and clinical trials have shown that the
low-density lipoprotein cholesterol (LDL-C) concentra-
tion is causally related to an increased risk of coronary
artery disease [1,2]. In addition, a report by the National
Cholesterol Education Program Adult Treatment Panel
III notes that the level of LDL-C is the primary variable
that is used to predict cardiovascular disease [1]. One* Correspondence: sjweng@thu.edu.tw
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unless otherwise stated.well-known formula for calculating this, the Friedewald
formula (FF), is of doubtful accuracy and precision, and
thus other approaches have been developed, such as
DeLong’s formula (DF) [3,4], Teerakanchana’s multiple
regression (MR) [5], Balal’s formula (BF), which is de-
rived from the FF [6], Tsai’s formula (TF) [7], calibrated
from TF (CTF) [8], and Tsai’s multiple regression
(TMR) [8]. All of these formulae measure the LDL-C con-
centrations based on total cholesterol (TC), high-density
lipoprotein cholesterol (HDL-C), and triglyceride (TG)
concentrations [9-12]. Several studies compare the various
methods used to assess the LDL-C concentration, and this. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Comparison of seven LDL-C formulae
Author Formula
Friedewald et al. [3] FF:
LDL-C = TC- (HDL-C) - (TG/5)
Balal et al. [6] BF:
LDL-C =8.018 + 0.99(LDL-C predicted by FF)
Delong et al. [4] DF:
LDL-C = TC- (HDL-C)- 0.16TG
Teerakanchanna et al. [5] MR:
LDL-C = 0.910TC - 0.634(HDL-C) - 0.111TG - 6.755
Tsai et al. [7] TF:
LDL-C = TC- (HDL-C) - (TG/8)
Tsai et al. [8] CTF:
LDL-C =0.276 + 0.997(LDL-C predicted by TF)
Tsai et al. [8] TMR:
LDL-C =0.988TC - 0.853(HDL-C) - 0.107TG - 8.703
Note: TC total cholesterol, LDL-C low density lipoprotein-cholesterol, HDL-C
high density lipoprotein-cholesterol, TG triglyceride.
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http://www.biomedcentral.com/1471-2261/14/113is likely due to rising healthcare expenditures as well as an
increasing demand for quality healthcare. It is thus highly
desirable to identify an accurate, a cost-effective method
to determine the LDL-C concentration.
Most clinical trials employ the FF [3], which uses TC,
HDL-C, and TG to measure the levels of LDL-C [5]; thus,
it can be applied to the clinical treatment and prevention
of atherosclerotic disease [6,8]. However, the FF has pro-
duced inaccurate results in some cases, and it is not rec-
ommended for use in the presence of hypertriglyceridemia
(>400 mg/dL) or type III hyperlipoproteinemia [13]. This
method also tends to underestimate LDL-C concentra-
tions [6,14-18] when the triglyceride concentration is nor-
mal [19,20] or less than 400 mg/dL [4,6,21,22]. Balal et al.
[6] thus revised the FF for use with renal transplant recipi-
ents by considering those with TG concentrations lower
than 400 mg/dL to calculate LDL-C levels. Teerakanchana
et al. [5] developed a multiple regression formula by using a
multiple linear regression model to test different data sets.
Tsai et al. [8] further took into account residual cholesterol
(RC), which consists of high-density lipoprotein cholesterol
(HDL-C), and revised the FF by using TG= 1/8 instead of
TG= 1/5, which represents very-low-density lipoprotein
cholesterol (VLDL-C).
LDL-C can now be measured directly using advanced
technologies, and while the time and cost of these
technologies continue to decrease, their costs remain
relatively high compared to using formulae to produce
estimates. LDL-C concentration may thus be deter-
mined in hospitals, at least in part, through best prac-
tice measures, and TMR is a valuable method for
providing benchmarking data [8]. However, no studies
to date have explored the use of formulae to estimate
LDL-C concentration among subjects of different ages
and genders. Measuring LDL-C without considering age
and gender may produce misleading results, because
one formula may perform well with one age group or
gender, but perform poorly with others. This study thus
compares all seven formulae shown in Table 1 in terms
of mean squared error (MSE), as well as underestima-
tion and overestimation of LDL-C concentrations, using
subjects of various ages and both genders.
Methods
Study population
The data used in this study was collected from Cheng
Ching General Hospital in Taiwan in 2011, with 3,532
valid samples obtained for measurement of LDL-C
concentration. All subjects were 20 to 95 years old, with
TG concentrations ≤ 400 mg/dL (n = 3,395; 96.1%) and >
400 mg/dL (n = 137; 3.9%). The subjects were classified
into three groups according to age, i.e., younger (20–44
years old), middle-aged (45–64 years old), and elderly
(65 years old and above). The subjects’ basic informationwith regard to TC, HDL-C, LDL-C, and TG is summa-
rized in Table 2. The maximum and minimum of TG
are 1252 and 22 mg/dL. Moreover, the maximum
values of TC, HDL-C, and LDL-C are 569, 126, and
444 mg/dL, respectively, whereas the respective mini-
mum values are 57, 3, and 20 mg/dL. Blood samples
were taken from all the subjects, and after clotting at
room temperature these were then centrifuged at
3000 rpm for 10 minutes, and the supernatants were
analyzed colorimetrically using a Hitachi 7600 analyzer.
Ethical approval for this study was obtained from the
Institutional Review Board of Cheng Ching General
Hospital in Taiwan (IRB No: HP140014).
In summary, six groups were examined in this study
based on age and gender: males 20–44 years old, 45–64,
and 65 and above, and females in the same three age
ranges. A total of 3,532 participants enrolled in the present
study (2,152 men and 1,380 women).Measurement
Two approaches are typically employed to evaluate
model adequacy. The first approach is to compare MSE,
which measures the dispersion around the true value of
the parameter. The lower the MSE value, the more ac-
curate the formula. The second approach is to compare
the underestimated and overestimated LDL-C values
with the real values based on the existing formulae. An
overestimate is defined as when the predicted value is
greater than the true value whereas an underestimate is
when the true value is greater than the predicted value.
Figure 1 MSE for all formulae with/without TG ≧400.
FF: Friedewald’s formula, BF: Balal’s formula, DF: DeLong’s formula,
MR: Teerakanchana’s multiple regression formula, TF: Tsai’s formula,
CTF: Calibrated from TF, TMR: Tsai’s multiple regression formula.
Table 2 Baseline characteristics of lipid profile
TC HDL-C LDL-C TG
Whole set of the data (n = 3532)
Mean 183.8 49.9 112.1 159.3
SD 40.1 15.3 34.3 110.3
Min. 57 3 20 22
Max. 569 126 444 1252
Q1 157 39 89 90
Median 181 48 110 130
Q3 208 58 132 192
Cases with TG≤ 400 (n = 3395)
Mean 182 50.4 111.8 143.8
SD 38.4 15.3 33.6 73.6
Min. 57 3 20 22
Max. 395 126 312 399
Q1 156 40 89 89
Median 179 48 110 125
Q3 205 59 132 182
Cases with TG > 400 (n = 137)
Mean 227.4 38.6 119.2 544.8
SD 54.2 10.1 49.7 158.1
Min 120 8 36 401
Max 569 73 444 1252
Q1 191 33 88 438
Median 223 38 115 486
Q3 252 44 140 594
TC total cholesterol, LDL-C low density lipoprotein-cholesterol, HDL-C high
density lipoprotein-cholesterol, TG triglyceride. SD standard deviation, Min.
minimum, Max. maximum, Q1 25% quartile, Q3 75% quartile.
All the units of lipid profile are mg/dL.
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This study carried out six experiments based on various
combinations of age and gender. The results are pre-
sented in two parts, as follows:
Study 1: Comparison of LDL-C MSE
Figure 1 displays the MSE performance of all formulae
with/without TG ≥ 400 mg/dL observations. These data
show that the FF and BF that exclude TG ≥ 400 mg/dL
have cutoffs of approximately 34% and 43%, respectively,
while the other formulae are less affected by TG concen-
tration. The FF is more accurate and precise when only
observations with TG ≤ 400 mg/dL are considered [3]. In
order to provide generalized benchmarking of the formu-
lae, our experimental data include all levels of TG, i.e., all
subjects were considered in the experimental analysis. The
experimental results (Figure 2a-2f) demonstrate that the
FF has the largest MSE value, which indicates that it has
the greatest differences between predictions and real ob-
servations. In fact, several studies have noted that the FF isknown to underestimate the LDL-C concentration [4,20].
In addition, the values predicted by MR, TF, CTF, and
TMR, which have lower MSE values than the other for-
mulae, are approximately half that of the vales predicted
by the FF formula for both age and gender categories in
our study. Furthermore, these four formulae also produce
less variability in the error bars, and therefore less uncer-
tainty in their predicted values (Figure 2a-2f).
Study 2: Comparison of LDL-C underestimation/
overestimation
Figure 3 shows the underestimated/overestimated per-
formance of all formulae with/without TG ≥ 400 mg/dL.
It is notable that the FF and BF have cutoffs of approxi-
mately 4% and 7% for the underestimated index without
TG ≥ 400 mg/dL, respectively. As has been previously
reported [3], FF is more accurate and precise when
the observations only consider a TG ≤ 400 mg/dL. To
provide generalized benchmarking for the formulae, our
experimental data include all levels of TG. The dotted
lines in Figure 4a-4f represent an underestimated LDL-C
prediction, i.e., when the predicted value is lower than
the result of a medical test. The solid lines represent an
overestimated LDL-C prediction, in which the predicted
value is higher than the result from the test. These results
show that the FF and DF tend to underestimate the LDL-C
concentrations. These two formulae were the most consist-
ent in terms of underestimating the LDL-C concentration
in all six groups, and their predictions were affected by age
and gender. BF and MR produced similar results to the FF
and DF, in that they underestimated the LDL-C concentra-
tion in most cases. However, BF and MR provided fewer
overall underestimated values compared to the FF and DF.
One finding of particular interest is that TF and CTF
both produce not only similar numbers of observations
a b 
c d 
e f 
Figure 2 MSE performance for genders in the different age groups. (a) MSE for males in the younger group (b) MSE for females in the
younger group (c) MSE for males in the middle-aged group (d) MSE for females in the middle-aged group (e) MSE for males in the elderly group
(f) MSE for females in the elderly group. FF: Friedewald’s formula, BF: Balal’s formula, DF: DeLong’s formula, MR: Teerakanchana’s multiple regression
formula, TF: Tsai’s formula, CTF: Calibrated from TF, TMR: Tsai’s multiple regression formula.
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mates (Figure 4a-4f ). Therefore, if there is a preference
for patient safety by virtue of overestimated predic-
tions of LDL-C, then TF and CTF can provide safer
and more accurate results. That is, underestimates of
LDL-C suggest that patients are in better health than
they really are, while overestimates can provide anearly warning for patients, so that they may choose to
have more advanced medical tests performed.
Based on the MSE performance findings of this study,
MR, TF, CTF, and TMR are preferable for estimating
LDL-C concentration, as there is less variability in their
results. We then assessed these formulae based on the
degree to which they overestimate or underestimate
Figure 3 Prediction performance for all formulae with/without
TG ≧400. FF: Friedewald’s formula, BF: Balal’s formula, DF: DeLong’s
formula, MR: Teerakanchana’s multiple regression formula, TF: Tsai’s
formula, CTF: Calibrated from TF, TMR: Tsai’s multiple regression formula.
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formed the best in the LDL-C concentration estima-
tions for all groups except females aged 20–44, with
Teerakanchana’s multiple regression (MR) providing
better results for this group. Moreover, TMR is a
formula that can be easily applied to all groups, even
though its performance among men and women aged
45–64 was slightly inaccurate than that of both TF and
CTF, because these latter two approaches tend to
underestimate the LDL-C concentration. Note that
CTF is a revised version of TF, and if both formulae
are recommended then TF should be used, because it
is simpler than CTF. It is anticipated that clinical prac-
titioners will be able to utilize the formulae bench-
marking table produced in this work (Table 3), in order
to choose the appropriate method for estimating LDL-
C concentration when age and gender are taken into
consideration.Discussion
The results shown in Figures 1 and 2 indicate that the
FF has relatively low accuracy. Although it exhibits
relatively good performance among older women
(aged 45 and above) with TG ≤ 400 mg/dL, its overall
performance is worse than that of the other formulae.
The formula with the best performance is TMR,
followed by TF, CTF, and MR, with no significant dif-
ferences among them, and the TF and CTF values in
particular being virtually identical. Due to the properties
of the multiple regression equation, the coefficients are
more complex for MR and TMR. In terms of ease of use,
TF is the preferred formula.According to Tsai’s analyses, the FF tends to under-
estimate LDL-C concentration by 10.1 mg/dL on aver-
age [7], while Balal et al. [6] report that the FF
underestimates it by 8 mg/dL, and other studies have
shown similar results [14-18]. Tsai’s results also
showed that the difference in the maximum and mini-
mum for the FF is larger than that of the other formu-
lae, and concluded that it is unsuitable for research on
epidemiological or causal relationships [7].
For all cases examined with/without TG ≥ 400 mg/
dL in this study, BF, the formula proposed by Balal
et al. [6], provided better results than the FF, although
it was still not as good as the other formulae. Tsai
et al. [7] report that BF has exactly the same R2 as the
FF, suggesting that BF only calibrated the underesti-
mation of the FF. These results demonstrate that while
the calibrated formula, acquired from the regression
of the estimated value and the measured value, could
produce an average estimated error that approaches
zero and hence reduce the estimated bias, this still
would not make the estimation more precise [7]. In
addition, an LDL-C formula is primarily used to pre-
cisely estimate the LDL-C concentration for individ-
uals, and while reducing the group estimated bias is
important, this only reduces part of the individual
estimated bias by expanding another part of it, and the
standard deviation of estimated error is not improved.
As shown in this study, BF is not able to replace the
FF or improve its shortcomings.
As noted above, the best performance for the FF was
in subjects with TG ≤ 400 mg/dL, although even among
these it was outperformed by the other formulae,
which provided stable results when age and gender
were taken into account.
Based on a multiple linear regression analysis of
1,016 cases, Teerakanchana et al. [5] obtained the for-
mula LDL-C = 0.910TC − 0.634(HDL-C) − 0.111TG −
6.755. Tsai et al. [8] also analyzed training data with
multiple linear regression, and found that LDL-C =
0.9882TC − 0.8526(HDL-C) − 0.1065TG − 8.7029, with
an R2 value similar to that of MR (R2 = 0.9649) and TF
(R2 = 0.9608). In the present study, the R2 values for
MR and TMR were determined to be 0.9648 and
0.9597, respectively; thus, there was no substantial
difference between them in this respect. Since mul-
tiple linear regression analysis, TMR, is far more com-
plex than TF, it is suggested that TF be used in most
cases.
Because LDL-C tests tend to be time-consuming and in-
convenient, the FF of LDL-C = TC − (HDL-C) − (VLDL-C)
is often clinically applied to produce estimates of this
value [3]. This formula assumes that the VLDL-C of
healthy adults, except those with type III hyperlipidemia,
is TG/5 [3,23,24] without chylomicrons. However, when
a b 
c d 
e f 
Figure 4 Prediction performance for genders in the different age groups. (a) Predictions for males in the younger group (b) Predictions for
females in the younger group (c) Predictions for males in the middle-aged group (d) Predictions for females in the middle-aged group (e) Predictions
for males in the elderly group (f) Predictions for females in the elderly group. FF: Friedewald’s formula, BF: Balal’s formula, DF: DeLong’s formula, MR:
Teerakanchana’s multiple regression formula, TF: Tsai’s formula, CTF: Calibrated from TF, TMR: Tsai’s multiple regression formula.
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underestimation of LDL-C, when TG chylomicrons
and related remnants appear in plasma [25]. FF also
assumes that TC only contains LDL-C, HDL-C, andVLDL-C, although it likely contains other constituents
as well. For example, it has been shown that TC also
contains intermediate-density lipoprotein cholesterol
(IDL-C), chylomicrons, VLDL-C remnants, lipoprotein
Table 3 Formulae benchmarking based on the
cross-validation of age and gender
Gender
Male Female
Age
MSE Under/Over Cross MSE Under/Over Cross
Validation* Validation*
20-44
MR MR TF TF BF MR
TF TF CTF CTF MR TF
CTF CTF TMR TMR TF CTF
TMR TMR CTF TMR
TMR
45-64
MR MR TF TF TF TF
TF TF CTF CTF CTF CTF
CTF CTF
TMR TMR
65+
MR MR TF TF TF TF
TF TF CTF CTF CTF CTF
CTF CTF TMR TMR TMR TMR
TMR TMR
Under/Over: Underestimate/Overestimate.
MR Teerakanchana’s multiple regression formula, TF Tsai’s formula,
CTF Calibrated formula, TMR Tsai’s multiple regression formula.
*: The formulae benchmarking.
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fied with current methods [26]. In this case, when the
contents other than HDL-C and LDL-C in TC are de-
fined as RC, then RC = TC − (HDL-C) − (LDL-C) would
be more accurate than using VLDL-C to estimate the
RC. When TG has a specific relationship with RC, it
would be more reasonable to estimate RC using TG [8].
When the regression analysis takes into account that
TC contains LDL-C, HDL-C, VLDL-C, IDL-C, chylomi-
crons, Lp(a), Lp-X, and other non-quantifiable fats, Tsai
et al. suggest revising the FF using TG = 1/8 instead of
TG = 1/5 [8].Research limitations
In this study, participants with diabetes, secondary
dyslipidemias (e.g., dyslipidemia due to renal, liver, or
thyroid disease), and those who were taking statins or
other lipid-modifying agents at the time of the enroll-
ment were not excluded. In addition, the extrapolation
of findings to other populations could introduce
errors. The experimental benchmarking is therefore
deemed specific for the Taiwanese cohort in this
study.
Some subjects with heritable hyperlipidemia have ex-
tremely high TG. However, the current study had fewcases with TG > 1500 mg/dL; these were not included
in the analyses. In addition, some related studies were
carried out after the subjects had fasted for 12 hours
[27,28], while in this study the subjects fasted for
8 hours, and this may have produced some discrepan-
cies with previous results, which is an issue that
requires further examination.
Conclusions
Advances in current testing technology have resulted
in efficient quantification of LDL-C concentration,
although the costs of these technologies are relatively
high. In contrast, estimating LDL-C concentration
using formulae can produce reliable results at a rela-
tively low cost, particularly when carrying out a large
number of tests. We compared the results of direct
homogeneous LDL-C assay with the FF, DF, MR, BF,
TF, CTF, and TMR for determination of LDL-C based
on underestimates/overestimates and MSE, using vari-
ous combinations of age and gender. In terms of pre-
diction errors and MSE, TF and CTF were the most
accurate with regard to LDL-C concentration, except
for women aged 20–44. Table 3 provides details for
benchmarking the formulae when considering age and
gender, and this could be a valuable reference for
clinical practitioners deciding on the best estimation
method for their particular situation.
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